Moderna-Merck Melanoma Vaccine Data Leaked at ESMO — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Moderna and Merck had data for a melanoma cancer vaccine presented early due to an embargo violation at the ESMO conference.
- The data leak disrupted the carefully laid reporting plans of journalists covering the European Society for Medical Oncology (ESMO) conference in Madrid.
- STAT+ reports that it was not responsible for the embargo breach that released the highly anticipated study results.
- The article is exclusive to STAT+ subscribers, who receive daily biotech sector coverage and analysis.
Why it matters: The premature leak of pivotal cancer vaccine data disrupts the controlled scientific communication process, potentially affecting market reactions and the integrity of conference presentations. For biotech investors and clinicians awaiting these results, the unplanned release creates an uneven information landscape.
Ask SkimNews
